Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virgilio Evangelista

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2010
Platelet-leukocyte interactions in cardiovascular disease and beyondLicia Totani, Virgilio Evangelista
European Journal of Pharmacology|August 22, 2006
The lipoxygenase-cyclooxygenase inhibitor licofelone prevents thromboxane A2-mediated cardiovascular derangement triggered by the inflammatory peptide fMLP in the rabbitSerenella Rotondo, Giuseppe Dell'Elba, Stefano Manarini, et al.
European Journal of Pharmacology|March 27, 2004
Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activationSerenella Rotondo, Katarzyna Krauze-Brzósko, Stefano Manarini, et al.
Thrombosis and Haemostasis|March 23, 2012
Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouseLicia Totani, Giuseppe Dell'Elba, Nicola Martelli, et al.
Prostaglandins & Other Lipid Mediators|February 15, 2012
Effects of estrogen on endothelial prostanoid production and cyclooxygenase-2 and heme oxygenase-1 expressionEmanuela Marcantoni, Luigia Di Francesco, Licia Totani, et al.
Thrombosis and Haemostasis|January 5, 2005
Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirinVirgilio Evangelista, Licia Totani, Serenella Rotondo, et al.
Thrombosis and Haemostasis|November 5, 2005
Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activationVirgilio Evangelista, Stefano Manarini, Giuseppe Dell'Elba, et al.
European Journal of Pharmacology|October 24, 2002
Licofelone, a dual lipoxygenase-cyclooxygenase inhibitor, downregulates polymorphonuclear leukocyte and platelet functionSerenella Rotondo, Giuseppe Dell'Elba, Katarzyna Krauze-Brzósko, et al.
Biochemical and Biophysical Research Communications|September 25, 2002
Inhibition of cGMP-dependent protein kinases potently decreases neutrophil spontaneous apoptosisMauro Brunetti, Nicola Mascetra, Stefano Manarini, et al.
Advances in Therapy|January 30, 2013
Effect of pioglitazone versus metformin on cardiovascular risk markers in type 2 diabetesStefano Genovese, Giorgia De Berardis, Antonio Nicolucci, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2010
Platelet-leukocyte interactions in cardiovascular disease and beyondLicia Totani, Virgilio Evangelista
European Journal of Pharmacology|August 22, 2006
The lipoxygenase-cyclooxygenase inhibitor licofelone prevents thromboxane A2-mediated cardiovascular derangement triggered by the inflammatory peptide fMLP in the rabbitSerenella Rotondo, Giuseppe Dell'Elba, Stefano Manarini, et al.
European Journal of Pharmacology|March 27, 2004
Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activationSerenella Rotondo, Katarzyna Krauze-Brzósko, Stefano Manarini, et al.
Thrombosis and Haemostasis|March 23, 2012
Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouseLicia Totani, Giuseppe Dell'Elba, Nicola Martelli, et al.
Prostaglandins & Other Lipid Mediators|February 15, 2012
Effects of estrogen on endothelial prostanoid production and cyclooxygenase-2 and heme oxygenase-1 expressionEmanuela Marcantoni, Luigia Di Francesco, Licia Totani, et al.
Thrombosis and Haemostasis|January 5, 2005
Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirinVirgilio Evangelista, Licia Totani, Serenella Rotondo, et al.
Thrombosis and Haemostasis|November 5, 2005
Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activationVirgilio Evangelista, Stefano Manarini, Giuseppe Dell'Elba, et al.
European Journal of Pharmacology|October 24, 2002
Licofelone, a dual lipoxygenase-cyclooxygenase inhibitor, downregulates polymorphonuclear leukocyte and platelet functionSerenella Rotondo, Giuseppe Dell'Elba, Katarzyna Krauze-Brzósko, et al.
Biochemical and Biophysical Research Communications|September 25, 2002
Inhibition of cGMP-dependent protein kinases potently decreases neutrophil spontaneous apoptosisMauro Brunetti, Nicola Mascetra, Stefano Manarini, et al.
Advances in Therapy|January 30, 2013
Effect of pioglitazone versus metformin on cardiovascular risk markers in type 2 diabetesStefano Genovese, Giorgia De Berardis, Antonio Nicolucci, et al.
Pageof 4